Sunday, July 22, 2018
 
 
Company News: Page (1) of 1 - 07/12/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
MedAvail Brings on Will Misloski as Chief Marketing Officer
 
(July 12, 2018)

MISSISSAUGA, ON, July 12, 2018 /PRNewswire/ - MedAvail announced Will Misloski as Chief Marketing Officer reporting directly to CEO Ed Kilroy. Will is a decisive marketing strategist who has specialized in growing companies by focusing on the consumer experience. 

At MedAvail, Will oversees all aspects of the customer experience, data analytics and the marketing strategy. His team uses data to tell the story of how marketing activities impact the customer journey and ultimately the business. 

Before joining MedAvail, Will was SVP Customer Marketing at Go Daddy, where he was responsible for the global customer marketing strategy. Under Will's direction, using the latest in marketing techniques and technologies, Go Daddy made huge strides in reducing customer churn.



Prior to Go Daddy, Will honed his marketing skills and experience to drive significant growth at both Raise and Nutrisystem and he was VP and General Manager at Orbitz. As part of the early Orbitz team, they created a world-class consumer experience, laying the foundation for the future acquisition of Orbitz Worldwide by Expedia.

Will holds a Bachelor of Science degree in Finance from the University of Illinois and a Master of Science degree in Integrated Marketing Communications from Northwestern University.

MedAvail Technologies Inc. is a healthcare technology company that has developed and commercialized an innovative Self-Serve Pharmacy Kiosk solution. The MedAvail MedCenter® supports the dispensing of prescription drugs and Over-the-Counter medications. MedAvail has deployed kiosks in the US, Canada and Switzerland in use cases that include employer sites, retail pharmacies, retail stores without traditional pharmacies, hospital emergency rooms, urgent cares, community clinics, universities and medical office buildings.

Pharmacies on a worldwide basis are identifying ways to extend their reach to gain market share. This involves optimizing current assets to include extending services within the pharmacy and implementing solutions to reduce the cost of dispense. Pharmacy business in developed countries are experiencing slow prescription growth, resulting in a drive towards gaining market share from competitors through innovative solutions. On the other hand, developing countries and markets are demonstrating accelerated growth in prescription medications, paving the way for easy deployment of The MedAvail MedCenter® as it is tailor-made to capture growth.

Cision View original content:http://www.prnewswire.com/news-releases/medavail-brings-on-will-misloski-as-chief-marketing-officer-300680387.html

SOURCE MedAvail Technologies Inc.

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Business,Science,Other,
Related Sites: DMN Newswire ,   itbusinessnet.com ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Vision Care Product Market To Witness Enhanced Growth Owing To Rising Occurrence Of Eye Disorders Till 2021 | Million Insights
  • Global Prosthetic Heart Valve Market Reaching at a CAGR of +12.70% by Geography, Deployment Model, Component, and Key players are Boston Scientific Cardiology, CryoLife, Inc., Abbott
  • Trauma Fixation Global Market to Register Steady Expansion During 2018-2025
  • Global Surgical Apparel Market Will Reach USD 2,966.58 million by 2024: Zion Market Research

    Cancer
  • CStone Pharmaceuticals Appoints Former Goldman Sachs Executive Richard Yeh as CFO
  • HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
  • Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody
  • Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia
  • Mesothelioma is a Deadly Cancer and it’s Completely Preventable
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines